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Background: The mechanism by which incomplete mitral leaflet coaptation
develops during ischemic mitral regurgitation is debated, with recent
studies suggesting that incomplete mitral leaflet coaptation may be due to
apically displaced papillary muscle tips. Yet quantitative in vivo three-
dimensional mitral leaflet motion during ischemic mitral regurgitation has
never been described. Methods: Radiopaque markers (sutured around the
mitral anulus, to the central free mitral leaflet edges, and to both papillary
muscle tips and bases) were imaged with the use of biplane videofluoros-
copy in six closed-chest, sedated sheep before (control) and during induc-
tion of acute ischemic mitral regurgitation. Leaflet coaptation was defined
as the minimum distance measured between edge markers during control
conditions. Results: During control, leaflet coaptation occurred 23 6 7 msec
(mean 6 standard error of the mean) after end-diastole, when left
ventricular pressure was 27 6 6 mm Hg. During ischemic mitral regurgi-
tation, coaptation was delayed to 115 6 19 msec after end-diastole (p <2 0.01
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vs control [n 5 4]) when left ventricular pressure was 88 6 4 mm Hg. At
end-diastole during ischemic mitral regurgitation, the mitral anulus area
was 14% 6 2% larger than control (7.4 6 0.3 cm2 vs 6.5 6 0.2 cm2, p <2
0.005) as the result of the lengthening of muscular annular regions (76.0 6
2.5 mm vs 70.5 6 1.4 mm, p <2 0.01). Mitral anulus shape (ratio of two
diameters) at end-diastole was more circular during ischemic mitral
regurgitation (0.79 6 0.01 vs 0.71 6 0.02, p < 0.01). At end-diastole during
ischemic mitral regurgitation, the posterior papillary muscle tip was
displaced 1.5 6 0.5 mm laterally and 2.0 6 0.6 mm posteriorly (p <2 0.02 vs
control), but there was no apical displacement of either papillary muscle
tip. Conclusions: Incomplete mitral leaflet coaptation during acute ischemic
mitral regurgitation occurred early in systole, not at end-systole, and was
due to “loitering” of the leaflets associated with posterior mitral anulus
enlargement and circularization, as well as some posterolateral, but not
apical, posterior papillary muscle tip displacement. These data suggest that
early systolic mitral anulus dilatation and shape change and altered
posterior papillary muscle motion are the primary mechanisms by which
incomplete mitral leaflet coaptation occurs during acute ischemic mitral
regurgitation. (J Thorac Cardiovasc Surg 1998;116:193-205)
Ischemic mitral regurgitation (MR) is a commonclinical problem, developing after myocardial in-
farction in up to 19% of patients.1 Some of these
individuals experience progressive symptoms of con-
gestive heart failure and ultimately require opera-
tive intervention to correct the MR. The choice of
what type of operative repair to use has been
generally based only on empirical notions gained
from clinical experience, because the exact mecha-
nism and pathogenesis of ischemic MR remain
unknown. Traditionally, MR in patients with heart
failure has been attributed to left ventricular (LV)
dilatation.2 Enlargement of the ventricle and LV
regional systolic wall motion abnormalities, how-
ever, are associated with dynamic alterations in the
three-dimensional (3-D) geometry of the mitral
valve and subvalvular apparatus itself3; these sec-
ondary abnormalities are more likely to be the
offending culprits responsible for ischemic MR.
Clearly, regurgitation occurs when there is incom-
plete mitral leaflet coaptation.4 Controversy arises,
however, from the lack of comprehensive informa-
tion regarding precisely what changes occur in the
mitral valve apparatus during myocardial ischemia
that cause incomplete mitral leaflet coaptation. Pre-
vious clinical and experimental reports have sug-
gested a myriad of sometimes conflicting possibili-
ties, including ischemic papillary muscle (PM)
dysfunction,5, 6 tethering of leaflets by apically dis-
placed PM tips,7, 8 leaflet prolapse secondary to PM
stretching,9 and dilatation and other geometric al-
terations in the mitral anulus (MA).10-12 These
proposed mechanisms do not fully explain the de-
velopment of ischemic MR; for example, simple ring
annuloplasty would not be expected to be effective
in patients with ischemic MR if the responsible
mechanism were merely related to restricted leaflet
motion (Carpentier type III)13 or alterations in the
3-D geometry of PM tips.
It is important to note that none of these previous
studies directly investigated the acute development
of incomplete mitral leaflet coaptation by assessing
in vivo 3-D mitral leaflet motion in a quantitative
manner during ischemic MR. Additionally, these
previous reports focused on end-systolic observa-
tions and largely ignored potential alterations in
mitral valve geometry that may occur at end-diastole
and in early systole, when normal mitral valve
closure occurs. As such, previously suggested mech-
anisms cannot fully account for the development of
ischemic MR because they did not include measure-
ment of the timing and other abnormalities in leaflet
coaptation.
In this study, using myocardial marker technolo-
gy14 in an ovine preparation, we analyzed continu-
ous 3-D motion of the mitral leaflet edges simulta-
neously with LV, PM, and MA dynamics in vivo to
define more clearly the mechanical pathogenesis of
incomplete mitral leaflet coaptation during acute
ischemic MR.
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Methods
Surgical preparation. Six healthy adult castrated male
sheep (62 6 10 kg [mean 6 standard deviation]) were
prepared for surgery,15 and miniature tantalum ra-
diopaque helices were inserted into the LV wall and
septum, as described previously.16
On cardiopulmonary bypass with the heart arrested,
miniature gold radiopaque markers were sutured to the
tips and bases of both PMs and to the central edges
(ventricular surface) of both mitral leaflets, as shown in
Fig. 1. Additional markers were sutured to the central
midbellies and bases (near the MA) of both leaflets (three
on the anterior and one on the posterior), but these
markers were not analyzed in the current study. Eight
additional miniature tantalum radiopaque markers were
sutured equidistantly around the circumference of the
MA, one near each commissural area (markers 1 and 5)
and three along the perimeters of the anterior (markers 6
through 8) and posterior (markers 2 through 4) leaflets. A
micromanometer pressure transducer (P4.5-X6; Konigs-
berg Instruments, Inc., Pasadena, Calif.) was placed in the
LV chamber via the apex.
Experimental protocol. After 8 6 2 (mean 6 SD) days,
each animal was taken to the experimental animal cardiac
catheterization laboratory for hemodynamic and videoflu-
orographic data acquisition. Details of the techniques
used have been previously reported.15 UL-FS49 (Boehr-
inger-Ingelheim, Ridgefield, Conn.), a highly specific neg-
ative chronotropic agent that does not change the QT
interval, inotropic state, or systolic or diastolic blood
pressure,17 was administered (8 mg intravenously) to
reduce the heart rate (facilitating subsequent cinefluoro-
scopic visualization and tracking of marker motion). To
minimize reflex sympathetic and parasympathetic re-
sponses that occur in conscious animals, autonomic block-
ade was accomplished with a low-dose intravenous infu-
sion of esmolol (20 to 50 mg/kg/min, titrated to reduce
heart rate below 110 min–1), and atropine sulfate (0.01
mg/kg intravenously).
An 8F coronary guiding catheter (Powerguide; Ad-
vanced Cardiovascular Systems, Inc., Temecula, Calif.)
was advanced into the left main coronary artery over a
0.014 inch floppy guide wire (HI-TORQUE; Advanced
Cardiovascular Systems, Inc.) through the 8F left femoral
artery sheath. A conventional 3.0 mm nonperfusion bal-
loon dilation catheter was then advanced through the
guiding catheter into the mid-left circumflex coronary
artery (distal to the first obtuse marginal artery).
For all data acquisition runs, hearts were in normal
sinus rhythm, and ventilation was arrested briefly at
end-expiration. All hemodynamic and biplane videofluo-
roscopic data recordings were obtained during steady-
state conditions and over a physiologic range of peak LV
systolic pressures during vena caval occlusion. Data re-
cordings were obtained first immediately before induction
of ischemia (control data). After 3 to 5 minutes of
stabilization, the balloon dilatation catheter in the mid-
left circumflex artery was inflated to 8 atmospheres com-
pletely occluding the artery. The balloon was kept inflated
for 3.1 6 0.3 (mean 6 SD) minutes, producing acute
posterolateral LV wall ischemia, resulting in MR as
verified and graded (by a single observer [A.F.B.] as none,
mild to moderate, or moderate to severe) using transtho-
racic Doppler echocardiography; data recordings were
repeated during coronary artery balloon occlusion (isch-
emic MR data). Data from premature ventricular contrac-
tions and immediate after extrasystolic beats were dis-
carded.
All animals received humane care in compliance with
the “Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research and the
“Guide for Care and Use of Laboratory Animals” pre-
pared by the National Academy of Sciences and published
by the National Institutes of Health (DHEW [NIH]
Publication 85-23, revised 1985). This study was approved
by the Stanford Medical Center Laboratory Research
Animal Review Committee and conducted according to
Stanford University policy.
Data acquisition. Images were acquired with the ani-
mal in the right lateral decubitus position with a Philips
Optimus 2000 biplane Lateral ARC 2/Poly DIAGNOST
C2 system (Philips Medical Systems, North America Com-
pany, Pleasanton, Calif.) with the image intensifiers in 90
fluoroscopic mode. Data from the two radiographic views
were digitized and processed to yield 3-D coordinates of
each marker every 16.7 msec. Specific details of this data
acquisition procedure have been described previously.16
Data analysis. Data from two consecutive steady-state
beats during both control and acute ischemic MR condi-
tions were averaged and defined as “control” and “isch-
emic” data, respectively.
Hemodynamics. For each cardiac cycle, the time of
end-diastole was defined as the videofluoroscopic frame
containing the beginning of positive deflection in electro-
cardiographic voltage (R-wave), and end-systole was de-
fined as the videofluoroscopic frame immediately before
Fig. 1. Schematic representation of the marker array.
The nine subepicardial LV markers, four PM markers,
and two mitral leaflet markers are depicted as black dots.
The eight MA markers are depicted as numbered circles.
APM, Anterior papillary muscles; PPM, posterior papil-
lary muscles.
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the frame that contained the point of peak negative LV
rate of pressure rise (dP/dt).
LV volume. Instantaneous LV volume was calculated
with a multiple elliptic cylindric/cone model.18 The eight
LV epicardial markers, eight MA markers, and one apical
marker (Fig. 1) define three cross-sectional marker layers
from base to apex. LV volume was computed as the sum
of the volumes of two elliptic cylinders and one elliptic
cone, as previously described.16 Although this computed
volume included myocardial volume, we have previously
shown that changes in this calculated volume accurately
reflect changes in LV chamber volume.19 Because the LV
volume calculations were made from epicardial measure-
ments, the calculated ejection fractions are underesti-
mates of the true ejection fractions.
Systolic LV function. We determined LV end-systolic
pressure (Pes) and volume (Ves) during preload reduction
using an iterative computer algorithm to define the end-
systolic pressure/volume relationship to assess LV systolic
performance.20 Least-squares linear regression was used
to fit a line of the form:
Pes 5 Ees ~Ves 2 V0!
to these end-systolic points, where Ees and V0 are the
slope and volume axis intercept of the end-systolic pres-
sure/volume relationship, respectively.
Mitral leaflet dynamics. Mitral leaflet coaptation was
defined as the minimum distance (5 mm) measured in 3-D
space between the leaflet edge markers during control
conditions. None of the animals had MR by transthoracic
Doppler echocardiography at this time. Leaflet edge
position in 3-D space was further defined by calculating
the angle (degrees; Fig. 2) between an MA reference
chord (defined from MA marker 3 to 7) and vectors from
MA marker 7 to the anterior leaflet edge marker (AML),
and from MA marker 3 to the posterior leaflet edge
marker (PML).
MA and PM geometry. MA area and perimeters were
computed from 3-D marker coordinates, without assum-
ing circular or planar geometry. MA area was calculated
as the sum of six triangular areas derived from triplets of
MA marker coordinates, and partial MA perimeters were
calculated as the sums of contiguous MA segment lengths
(Fig. 1). MA and PM dimensions were also computed
from 3-D marker coordinates. The septal-lateral MA
dimension was calculated as the linear distance in 3-D
space between MA markers 3 and 7 (middle of the
anterior MA to a corresponding locus on the posterior
MA), and the commissure-commissure MA dimension
was computed as the linear distance in 3-D space between
MA markers 1 and 5 (Fig. 1). The septal-lateral/commis-
sure-commissure ratio was used as a measure of MA
eccentricity (a ratio of 1.0 signifies a circle, with eccentric-
ity increasing as the ratio decreases). PM lengths were
calculated as linear distances in 3-D space between the
PM tip and base markers.
Mitral apparatus shape was analyzed further with a 3-D
coordinate system defined with the origin at the midpoint
of the commissural markers (markers 1 and 5), and the
negative z-axis directed through the LV apical marker
(i.e., along the LV long axis). This system allowed the
description of the location of any marker in 3-D coordi-
nates; positive z coordinates were nearer the atrium, and
negative z coordinates were closer to the LV apex.
Statistical analysis. All data are reported as mean 6 1
standard error of the mean, unless otherwise stated.
Hemodynamic and marker-derived data from two consec-
utive steady-state beats in six hearts were time-aligned at
the upstroke of the electrocardiographic R-wave (end-
diastole; only four animals contributed data to the leaflet
edge marker analysis because at least one leaflet marker
had become dislodged postoperatively in the other two
sheep). The mean and SEM for each variable were
computed for the 12 beats (8 beats for leaflet data) at
end-diastole and at 16 time samples before (267 msec)
and after end-diastole, such that a curve could be gener-
ated depicting the behavior of any variable throughout
one cardiac cycle (534 msec in this experiment [104
min–1]). Repeated measures of analysis of variance was
used to detect whether there appeared to be significant
differences between end-diastole and end-systole values of
the variables of interest and whether these values were
affected by the factor of circumflex coronary artery bal-
loon occlusion (i.e., ischemia). In cases where a difference
was evident, mean differences were tested for significance
(compared with zero) by Student’s t test for dependent
observations, with Bonferroni’s correction for multiple
comparisons.
Results
Postmortem examination of excised hearts re-
vealed all LV epicardial markers to be within 1 mm
of the epicardial surface, all eight MA markers to be
within 1 mm of the MA (as defined by the leaflet–
left atrial endocardium junction), and all the PM
markers to be present.
Hemodynamics. Acute MR was successfully in-
duced in all six sheep by circumflex coronary artery
balloon occlusion; four sheep had mild to moderate
MR, and two had moderate to severe MR. The two
sheep that were missing leaflet edge markers at the
time of data acquisition were in the mild to moder-
ate MR group. No animal had evidence of MR
before circumflex occlusion.
Fig. 2. Diagram demonstrating UAML and UPML, as cal-
culated in degrees from the reference chord between MA
markers 3 and 7. Mitral leaflet edge markers are repre-
sented by black dots.
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The average heart rate for all sheep did not differ
between preischemic control and acute ischemic
MR conditions (107 6 5 vs 101 6 8 min–1, p 5 NS).
End-diastolic LV pressure did not increase with
acute ischemia (16 6 2 vs 14 6 1 mm Hg, p 5 NS),
but peak systolic LV pressure fell significantly 141 6
8 vs 102 6 6 mm Hg, p # 0.005). Additionally,
although global LV systolic function, as assessed by
Ees, did not change significantly during ischemia
(3.0 6 0.3 mm Hg/ml vs 3.3 6 0.09 mm Hg/ml, p 5
NS), LV ejection fraction decreased by 30% 6 8%
(21% 6 1% vs 14% 6 1%, p # 0.02); LV stroke
work decreased by 47% 6 19% (4024 6 561 mm
Hg z ml vs 2030 6 367 mm Hg z ml, p # 0.005), and
LV dP/dtmax decreased by 22% 6 5% (1622 6 103
mm Hg/sec vs 1254 6 90 mm Hg/sec, p # 0.001).
These hemodynamic alterations are consistent with
a moderate degree of acute regional LV ischemia
accompanying balloon occlusion.
Mitral leaflet dynamics. Fig. 3 shows the changes
in LV pressure and distance between the mitral
leaflet edge markers versus time for all animals
during both control and ischemic conditions. During
control, mitral leaflet edge marker separation
reached 5 mm (defined as coaptation) 23 6 7 msec
after end-diastole, when LV pressure was 27 6 6
mm Hg (19% 6 4% of peak systolic LV pressure).
During acute ischemic MR, mitral leaflet edge
marker separation also ultimately reached 5 mm,
but the time of this coaptation was significantly
delayed to 115 6 19 msec after end-diastole (p #
0.01 vs control), when LV pressure had already risen
to 88 6 4 mm Hg (86% 6 3% of peak systolic LV
pressure). It is important to note that abnormalities
in the motion of both leaflets contributed to this
delayed coaptation (Fig. 2). At end-diastole with
acute ischemia, UAML increased from 36 6 1 de-
grees to 41 6 2 degrees (p # 0.001), and UPML
increased from 61 6 1 degrees to 65 6 3 degrees
(p # 0.01); however, at end-systole there were no
such differences between control and ischemic con-
ditions in UAML and UPML. Moreover, there was no
apical displacement of either mitral leaflet edge
marker at the time of coaptation. The distance from
the MA (measured along the LV long axis) to the
point of coaptation did not change during acute
ischemia (7.5 6 0.5 mm vs control 8.0 6 0.4 mm, p 5
NS), even though the timing of coaptation differed
between the two conditions.
MA shape, geometry, and motion. Fig. 4 shows
the changes in MA area, partial MA perimeters
(muscular and fibrous regions), septal-lateral and
commissure-commissure dimensions, and septal-lat-
eral/commissure-commissure ratio versus time for
all animals during control and acute ischemic MR
conditions. The area of the MA orifice was larger
during acute ischemic MR than during control at all
times in the cardiac cycle. Although overall MA area
shrinkage from maximum to minimum was reduced
during acute ischemia (11% 6 1% vs 15% 6 2%,
p # 0.02), the amount of presystolic area shrinkage
was unchanged (74% 6 16% vs 85% 6 6% of total
area shrinkage, p 5 NS). More important, however,
the increase in MA area during acute ischemia
reached a maximum of 14% 6 2% larger than
control at end-diastole (7.4 6 0.3 cm2 vs 6.5 6 0.2
cm2, p # 0.005) but was only 9% 6 2% larger than
control at end-systole (7.4 6 0.3 cm2 vs 6.8 6 0.2
cm2). This MA enlargement involved dilatation of
the muscular regions of the MA only (e.g., 76.0 6
2.5 mm vs 70.5 6 1.4 mm at end-diastole, p # 0.01);
the length of the intertrigonal (or anterior) MA
region was unchanged during acute ischemia at all
times in the cardiac cycle, as depicted graphically in
Fig. 5.
The MA septal-lateral and commissure-commis-
sure dimensions reflected changes in MA shape. As
seen in Fig. 4, septal-lateral MA dimension was
larger during acute ischemia than during control
conditions throughout the cardiac cycle, with a
maximum difference of 13% 6 3% again occurring
at end-diastole (27.8 6 0.6 mm vs 24.6 6 0.2 mm,
p # 0.005). The commissure-commissure dimension
increased slightly with acute ischemia but was sig-
nificantly larger than control only at end-systole
(34.6 6 0.6 mm vs 33.6 6 0.5 mm, p # 0.02), when
the leaflets had already coapted; at end-diastole this
difference was not significant (35.3 6 0.9 mm vs
34.6 6 0.6 mm, p 5 NS). Consequently, the annular
septal-lateral/commissure-commissure ratio was sig-
nificantly larger during acute ischemia (i.e., a more
circular anulus) throughout the cardiac cycle, again
with the greatest relative difference between control
and ischemic conditions occurring at end-diastole
(0.79 6 0.01 vs 0.71 6 0.02, p # 0.01). Additionally,
at end-systole during acute ischemia there was re-
duction in the height above the intercommissural
midpoint of the anterior MA “saddlehorn” near the
aortic valve (6.1 6 0.8 mm vs 7.7 6 0.9 mm) as
previously reported,12 but this shape perturbation
was not observed at end-diastole.
LV and PM dynamics and geometry. To deter-
mine whether the observed end-diastole MA en-
largement was simply a consequence of LV dilata-
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tion, we compared various LV dimensions before
and during acute ischemia. Fig. 6 depicts LV vol-
ume, the distances between the anterior and poste-
rior PM tips and bases, and the lengths of both PMs
versus time. Although LV volume was larger at
end-systole during acute ischemia (134 6 18 ml vs
122 6 14 ml, p # 0.001), LV volume at end-diastole
was not changed (157 6 21 ml vs 154 6 21 ml, p 5
NS). Similarly, the PM tip-to-tip (26.6 6 0.6 mm vs
26.3 6 0.6 mm, p 5 NS) and PM base-to-base
(25.9 6 2.1 mm vs 25.6 6 1.8 mm, p 5 NS)
dimensions at end-diastole did not change during
acute ischemia. Finally, the end-diastolic length of
the LV long axis was not changed by acute ischemia
(81.8 6 2.7 mm vs 82.1 6 2.9 mm, p 5 NS). Not
surprisingly, because ejection fraction was signifi-
cantly reduced, LV volume at end-systole was in-
creased during acute ischemia (135 6 7 ml vs 123 6
6 ml, p # 0.001), with corresponding increases at
end-systole in the PM tip-to-tip (23.1 6 0.7 mm vs
20.1 6 0.7 mm, p # 0.01) and PM base-to-base
(20.4 6 1.9 mm vs 17.6 6 1.1 mm, p # 0.05)
dimensions. These increases in LV dimensions at
end-systole during acute ischemia, however, could
not have contributed to the observed incomplete
mitral leaflet coaptation, because the valve was
already closed at this end-systolic time.
Analysis of PM dynamics (Fig. 6) revealed that
anterior PM systolic shortening (from end-diastole
to end-systole) was unaffected by acute posterolat-
eral ischemia, as expected. Shortening of the poste-
rior PM was abolished by acute ischemia, and the
posterior PM actually lengthened during systole
(–3% 6 3% vs 9% 6 1%, p # 0.02); this lengthening
resulted in increased posterior PM length at end-
systole (22.1 6 2.2 mm vs 19.6 6 1.8 mm, p # 0.02).
On the other hand, posterior PM length was un-
changed during acute ischemia at end-diastole
(21.5 6 2.1 mm vs 21.8 6 2.2 mm, p 5 NS), the time
when leaflet “loitering” began. We also compared
the position in 3-D space of both PM tips before and
during acute ischemia to determine whether either
PM was abnormally displaced at the time of incom-
plete mitral leaflet coaptation. As shown in Figs. 5
and 7, the position of the anterior PM tip did not
change at end-diastole during acute ischemia, but
the posterior PM tip became dislocated 1.5 6 0.5
mm towards the LV lateral wall and 2.0 6 0.6 mm
towards the posteromedial commissural area (p #
0.02 vs control). It is important to note that this
displacement allowed the position of the posterior
PM tip to remain relatively constant with relation to
the MA (i.e., the posterior PM was displaced in a
similar direction as MA enlargement; Fig. 5). Al-
Fig. 3. LV pressure (LVP; solid and open squares) and mitral leaflet edge separation (solid and open
circles) versus time for control (solid line) and ischemic MR (dashed line) conditions. Data are composite
average values for all animals (n 5 4 for leaflet edge separation), with error bars representing 6 1 SEM.
The graph depicts one cardiac cycle extending from beginning diastole to end-systole (vertical shaded box),
with data aligned at the upstroke of the electrocardiographic R wave (end-diastole, defined by the vertical
line at t 5 0). Delayed mitral leaflet coaptation during ischemic MR occurred in early systole, when the
leaflets “loitered” (arrow) before ultimately coapting in mid-systole. Note that the valve was closed at
end-systole during ischemic MR.
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though at end-systole, there was some displacement
of the posterior PM tip toward the MA (0.9 6 0.3
mm) and of the anterior PM tip toward the LV apex
(0.6 6 0.2 mm), we observed no such displacement
of either PM tip at the time of incomplete mitral
leaflet coaptation (Fig. 7).
Discussion
Various mechanisms have been proposed to ex-
plain the development of MR after myocardial
ischemia or infarction. Most of these theories fo-
cused on geometric alterations occurring within the
ventricle and/or mitral subvalvular apparatus during
acute myocardial ischemia. It has previously been
thought that the time within the cardiac cycle when
these acute changes are most important is late
systole and end-systole, and thus any observed end-
systolic changes in mitral apparatus geometry were
promoted as causative factors in the pathogenesis of
ischemic MR. In this first study of 3-D mitral leaflet
geometry and motion, we present direct novel evi-
dence of incomplete mitral leaflet coaptation occur-
ring in vivo in early systole during acute posterolat-
eral LV wall ischemia, coinciding with significant
end-diastolic geometric alterations in the mitral
valve complex.
Mitral leaflet dynamics. We defined central leaf-
let coaptation as the minimum distance (5 mm)
measured between the leaflet edge markers during
control conditions, when no MR was noted on
Doppler echocardiography. As such, it can be seen
from Fig. 3 that the mitral valve was ultimately
Fig. 4. MA area, length of muscular regions of the MA
(Musc.), length of the intertrigonal fibrous regions of the
MA (Fibr.), septal-lateral dimension (SL), commissure-
commissure dimension (CC), and ratio of septal-lateral to
commissure-commissure dimensions (SL/CC) versus time
for control (solid line) and ischemic MR (dashed line)
conditions. Data are composite average values for all
animals, with error bars representing 1 SEM. The graphs
each depict one cardiac cycle extending from beginning
diastole to end-systole (vertical shaded box), with data
aligned at the upstroke of the electrocardiographic R
wave (end-diastole, defined by the vertical line at t 5 0).
Fig. 5. Projection of the MA, eight annular markers
(numbered), and two PM tip markers in the zero plane, as
viewed from the left atrium at end-diastole for control
(solid line and circles) and ischemic MR (dashed line, open
circles) conditions. Data are group mean marker position,
with the origin at the intercommissural midpoint (between
markers 1 and 5). Note that the annular enlargement
during ischemic MR was confined to the muscular regions
of the anulus (i.e., all segments but those between markers
6, 7, and 8) and that the PPM tip was displaced in a similar
direction as annular enlargement. RFT, Right fibrous
trigones; PC, posteromedial commissural areas; PPM,
posterior papillary muscles; LFT, left fibrous trigones;
APM, anterior papillary muscles; AC, anterolateral com-
missural areas.
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closed by the time of end-systole during both control
and acute ischemic MR conditions; the delay in
leaflet coaptation during acute ischemic MR oc-
curred in early systole only. Importantly, this de-
layed closure involved abnormal motion of both
mitral leaflets, indicating that proper closing of both
mitral leaflets is essential for effective valve closure.
Also, the locations (with relation to the MA) of both
central leaflet edge markers at the time of coapta-
tion were unchanged by acute ischemia, that is,
there was no “apical displacement” of the coapta-
tion zone as suggested previously.7, 8 These earlier
studies, however, were based on two-dimensional
echocardiographic data acquisition and therefore
Fig. 6. LV volume (LVV), distance between papillary tips (Tip-Tip), distance between papillary bases
(Base-Base), length of anterior PM (APM), and length of posterior PM (PPM) versus time for control (solid
line) and ischemic MR (dashed line) conditions. Data are composite average values for all animals, with
error bars representing 6 1 SEM. The graphs each depict one cardiac cycle extending from beginning
diastole to end-systole (vertical shaded box), with data aligned at the upstroke of the electrocardiographic
R wave (end-diastole, defined by the vertical line at t 5 0). Note that LV enlargement and posterior PM
lengthening occurred at end-systole only, when the valve was already closed.
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could not accurately determine the point of coapta-
tion in 3-D space. The current 3-D marker data
therefore shed new light on the pathogenesis of
acute ischemic MR.
MA shape, geometry, and motion. As compared
with control measurements, MA area was larger
during acute ischemic MR throughout the entire
cardiac cycle, with the greatest relative increase
being observed at end-diastole, precisely the time
when delayed leaflet coaptation began. This en-
largement was confined to the muscular, mostly
posterior, MA (Figs. 4 and 5).12, 21 It may seem as
though a 14% 6 2% increase in MA area would be
insufficient to produce incomplete mitral leaflet
coaptation given the tremendous natural redun-
dancy or “surplus” of leaflet tissue available, but this
value is nearly equivalent to the overall maximum to
minimum area shrinkage of 15% 6 2% that occurs
in the normal ovine MA. More important, during
acute ischemia, the smallest MA area at any time in
the cardiac cycle (7.5 6 0.3 cm2) was equivalent to
the largest MA area reached during control condi-
tions (7.5 60.2 cm2), emphasizing the physiologic
significance of this degree of MA enlargement.
Although Gorman and associates22 have suggested
that acute ischemic MR does not result from MA
dilatation, their data pertained to end-systole mea-
surements only; they did not discuss end-diastolic
measurements. Interestingly, the finding reported by
Gorman and associates22 of flattening of the MA
“saddlehorn” at end-systole concurs with our obser-
vations at end-systole; however, no such flattening
occurred at end-diastole, when the period of leaflet
“loitering” started. Thus this perturbation in annu-
lar height cannot explain our new findings of early
systolic incomplete mitral leaflet coaptation.
The MA orifice was not only dilated during acute
ischemic MR, but its cross-sectional shape was
altered as well. Because the septal-lateral dimension
enlarged significantly more than the commissure-
commissure dimension during acute ischemia at
end-diastole, the MA was more circular in early
systole when incomplete mitral leaflet coaptation
occurred. This increase in septal-lateral dimension
and subsequent annular “circularization” in con-
junction with MA dilatation would tend to com-
pound the separation of the leaflet edge markers,
thereby augmenting the extent of incomplete mitral
leaflet coaptation.
We previously demonstrated similar changes in
MA orifice size and shape at end-diastole when
normal left atrial contraction was abolished,15 but in
the current study there was no evidence of less
presystolic MA area shrinkage during acute isch-
emia (74% 6 16% vs 85% 6 6%, p 5 NS), probably
reflecting no change in normal left atrial function.
Because both atrial and ventricular fibers insert into
the mitral ring23, 24 and because the fibers of ven-
tricular origin are circumferentially arranged (al-
though those of atrial origin are perpendicularly
oriented),25 it is likely that the observed MA geom-
etry changes resulted from diminished contractile
function and dyskinesis of the LV fibers inserted
into the posterior mitral ring. Such dyskinesis and
loss of contractile function would result in length-
ening of these fibers at all times in the cardiac cycle.
As such, overall MA orifice size was larger and its
shape was more circular, even though presystolic
area shrinkage was conserved.
LV and PM dynamics and geometry. These ob-
servations indicate that LV dilatation or shape
change cannot be implicated as causing acute isch-
emic MR. Although these data agree with previously
reported findings that myocardial ischemia produces
LV enlargement and probable LV shape changes at
end-systole,20, 26 there were no such changes at
end-diastole, when the observed delay in mitral
Fig. 7. Schematic of the MA with eight annular markers
(numbered), anterior PM (APM) with tip and base mark-
ers, and posterior PM (PPM) with tip and base markers in
the anterior-posterior projection at end-diastole for con-
trol (solid line and circles) and ischemic MR conditions
(dashed line, open circles). Data are mean marker posi-
tions, with the origin at the intercommissural midpoint
(between annular markers 1 and 5). Negative values along
the ordinate are toward the LV apex. Note that neither
PM tip was displaced apically at end-diastole (the time
when leaflet loitering began). AC, Anterolateral commis-
sural areas; PC, posteromedial commissural areas.
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leaflet coaptation started. As such, these LV geo-
metric changes cannot explain early systolic MR
during acute myocardial ischemia. The same is true
of alterations in PM geometry. Although the poste-
rior PM was dyskinetic during systole, resulting in
end-systolic lengthening (as previously reported6, 9),
there was no difference in length of either PM
during the time of incomplete mitral leaflet coapta-
tion in early systole. Thus prolapse of leaflet edges
attached to an elongated posterior PM cannot ex-
plain early systolic incomplete mitral leaflet coapta-
tion. Additionally, we found no evidence of apical
displacement of either PM tip in early systole at the
time of incomplete mitral leaflet coaptation. This
finding concurs with previous observations from this
laboratory in dogs where apical displacement of
either PM tip was absent in early systole during
acute ischemic MR.27 We did, however, detect other
small displacements in the 3-D end-diastolic loca-
tion of the posterior, but not the anterior, PM tip
during ischemia, that is, the posterior PM tip moved
laterally and posteriorly. The location of the poste-
rior PM tip in relation to the MA, however, was not
significantly different, as seen in Figs. 5 and 7.
Consequently, it is likely that mechanisms other
than PM dysfunction and PM apical displacement
are responsible for the development of acute isch-
emic MR in sheep.
Surgical implications. The observations in this
experiment reveal that acute posterolateral LV isch-
emia results in early systolic incomplete mitral leaf-
let coaptation and MR, which is associated primarily
with significant end-diastolic MA enlargement and
shape change, and small alterations in posterior PM
tip location. Conversely, no changes in LV geome-
try, leaflet prolapse, or apical displacement of any
part of the mitral apparatus were seen at end-
diastole when leaflet “loitering” started. Thus these
data do not support the clinical notion that acute
ischemic MR is merely an end-systolic phenome-
non. It is true that multiple 3-D geometric pertur-
bations in the mitral subvalvular apparatus do
occur at end-systole, as this and previous experi-
ments6, 8, 9, 21, 22, 26 have demonstrated; however,
it is possible that most of the MR actually occurs
earlier solely as the result of early systolic incom-
plete mitral leaflet coaptation in the central re-
gions of the leaflets, which is attributable primarily
to MA dilatation. This early systolic MR during
acute ischemia may thus be the initial inciting event
that ultimately leads to more MR and then chronic
LV volume overload, with eventual subsequent
worsening of MR over time. As such, these data may
provide a new foundation for use of ring annulo-
plasty (i.e., beneficial effects at end-diastole and
during early systole). It also is clear why a ring can
work in patients with ischemic MR. By reducing the
size of the MA, the leaflet edges are brought closer
together thereby allowing coaptation to occur more
readily. Because MA dilatation was confined to the
muscular (posterior) MA, patients with ischemic
MR may only need a partial (posterior) annulo-
plasty ring rather than a complete ring; conversely, a
complete ring with restoring “hoop” forces applied
across the septal-lateral axis may minimize the end-
diastolic “circularization” we observed. Moreover,
detection of incomplete mitral leaflet coaptation at
the center of the mitral valve leaflets during isch-
emic MR lends support to the “edge-to-edge” or
“bow tie” technique of mitral valve repair proposed
by Fucci and colleagues.28 Suturing the central free
edges of the mitral leaflets together will certainly
inhibit the development of central incomplete mitral
leaflet coaptation even in the absence of an annu-
loplasty ring; however, incomplete mitral leaflet
coaptation could theoretically still occur on either
side of the suture involving the “figure of 8” double
mitral orifice.
On the other hand, it is important to consider the
possibility that the observed end-systolic 3-D geo-
metric perturbations in the mitral subvalvular appa-
ratus also caused MR; in other words, acute isch-
emic MR (at least in sheep) could also be due to
incomplete mitral leaflet coaptation in the medial
and lateral regions of the valve leaflets, which were
not examined in this experiment. Future 3-D dy-
namic studies of leaflet motion in these other valve
regions are necessary to define more completely the
behavior of all parts of the mitral leaflets throughout
the entire cardiac cycle. In addition, further studies
of MA fixation with and without myocardial isch-
emia are needed to determine whether or not MA
area reduction alone (i.e., isolated ring annulo-
plasty) is sufficient to prevent the development of
ischemic MR. Ongoing sheep studies in our labora-
tory have been designed to address these questions.
Limitations. The use of myocardial markers for
3-D assessment of cardiac dynamics has obvious
limitations. First, although this technology allows
accurate and reproducible determination of 3-D
marker position every 16.7 msec with a mean overall
error of only 0.1 6 0.6 mm,29 it requires suturing
small metallic markers to the area of interest, in this
case the mitral leaflets, MA, and PM tips and bases.
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The possibility of markers interfering with normal
motion of these structures, particularly the leaflets,
should be considered; however, because the markers
are small (20 6 6 mg) their effect is probably
inconsequential. In fact, preliminary data from our
laboratory revealed that the peak velocity of the
anterior mitral leaflet edge marker (calculated from
60 Hz marker data) was 0.49 6 0.03 m/sec, which is
of the same order of magnitude as the 0.3 to 0.4
m/sec speed of the anterior mitral leaflet in human
beings and in sheep without leaflet markers (calcu-
lated from M-mode echocardiography recorded at
225 Hz).
Second, because markers were inserted only on
the central region of the mitral leaflets in this initial
study of 3-D mitral leaflet motion, no data are
available concerning coaptation or motion of other
parts of the leaflet edges. Thus in the present study
we cannot rule out the possibility that incomplete
mitral leaflet coaptation occurred posteromedially
or anterolaterally. This investigation, however,
clearly demonstrates that incomplete mitral leaflet
coaptation during acute ischemic MR occurs at least
in the central portion of the valve and that this
phenomenon takes place in early systole. Although
adding more markers to other aspects of the mitral
valve leaflets would increase our knowledge about
the mechanism(s) of ischemic MR in other regions
of the leaflets, the additional marker mass might be
sufficient to exert inertial effects that could artifac-
tually perturb leaflet motion independent of isch-
emia. We are currently working to design an animal
model with smaller markers arranged in a denser
array on the leaflet edges to elucidate more clearly
the behavior of the anterolateral and posteromedial
aspects of the mitral valve during ischemic MR.
Other limitations lie in the use of the animal
model. This experiment was conducted in mature
sheep, which have been reported to have a less
well-defined posterior MA than human beings, with
a greater amount of left atrial tissue above and
below the mitral leaflet hinge points. A recent study
has shown, however, that the amount of left atrial
muscle fiber in the human mitral ring is quite
variable; therefore it may be more like the sheep’s
MA than previously thought.24 In addition, this
study examined only the effects of acute posterolat-
eral LV wall ischemia. Other ischemic insults, for
example regional anterior wall or global LV isch-
emia, both acute and chronic, need to be investi-
gated. Because chronic volume overload as the
result of MR will ultimately result in LV remodeling
and other geometric alterations in the ventricle and
mitral subvalvular apparatus, the inferences drawn
from acute studies may not be directly applicable to
dilated human hearts with limited LV systolic re-
serve as a result of chronic MR because of previous
myocardial ischemia and/or infarction. Additional
experiments in an animal model of long-standing
LV volume overload as a consequence of chronic
MR are necessary to define the relevance of these
data to the broad spectrum of current surgical
practice. We are currently considering an experi-
mental model of dilated cardiomyopathy to address
this question.
We thank Byron W. Brown, PhD, Professor of Biosta-
tistics at Stanford University, for his help and Mary K.
Zasio, BA, Erin M. Schultz, BS, and Carol W. Mead, BA,
for their technical assistance.
R E F E R E N C E S
1. Hickey M StJ, Smith RL, Muhlbaier LH, Harrell FE, Reves
JG, Hinohara T, et al. Current prognosis of ischemic mitral
regurgitation: implications for future management. Circula-
tion 1988;78(Suppl):I51-9.
2. Friedberg CK. Mitral valvular disease. In: Diseases of the
heart. 3rd ed. Philadelphia: WB Saunders; 1966. p. 1030-3.
3. Perloff JK, Roberts WC. The mitral apparatus: functional
anatomy of mitral regurgitation. Circulation 1972;46:227-39.
4. Kaul S, Spotnitz WD, Glasheen WP, Touchstone DA. Mech-
anism of ischemic mitral regurgitation: an experimental
evaluation. Circulation 1991;84:2167-80.
5. Phillips JH, Burch GE, DePasquale NP. The syndrome of
papillary muscle dysfunction: its clinical recognition. Ann
Intern Med 1963;59:508-20.
6. Gorman RC, McCaughan JS, Ratcliffe MB, Gupta KB, Guy
TS, Edmunds LH. A three-dimensional analysis of papillary
muscle spatial relationships in acute postinfarction mitral
insufficiency. Surg Forum 1994;45:330-4.
7. Dion R. Ischemic mitral regurgitation: When and how should
it be corrected? J Heart Valve Dis 1993;2:536-43.
8. Stewart WJ, Sun JP, Mayer E, Lytle BW, Cosgrove DM.
Mitral regurgitation with normal leaflets results from apical
displacement of coaptation, not annular dilation [abstract].
Circulation 1994;90(Suppl):I311.
9. Gorman JH, Gorman RC, Jackson BM, Hiramatsu Y,
Gikakis NS, Kelley ST, et al. Distortions of the mitral valve in
acute ischemic mitral regurgitation [abstract]. Program of the
33rd Annual Meeting of the Society of Thoracic Surgeons
1997. p. 226.
10. Stewart WJ, Currie PJ, Salcedo EE, Klein AL, Marwick T,
Agler DA, et al. Evaluation of mitral leaflet motion by
echocardiography and jet direction by Doppler color flow
mapping to determine the mechanism of mitral regurgitation.
J Am Coll Cardiol 1992;20:1353-61.
11. Rankin SJ. Improving surgical strategies for ischemic mitral
regurgitation. J Heart Valve Dis 1993;2:533-5.
12. Glasson JR, Komeda M, Daughters GT, Bolger AF, Mac-
Isaac A, Oesterle SN, et al. Three-dimensional dynamics of
The Journal of Thoracic and
Cardiovascular Surgery
Volume 116, Number 2
Glasson et al. 2 0 3
the canine mitral annulus during ischemic mitral regurgita-
tion. Ann Thorac Surg 1996;62:1059-68.
13. Carpentier A. Cardiac valve surgery: the “French correc-
tion.” J Thorac Cardiovasc Surg 1983;86:323-37.
14. Ingels NB, Daughters GT, Stinson EB, Alderman EL. Mea-
surement of midwall myocardial dynamics in intact man by
radiography of surgically implanted markers. Circulation
1975;52:859-67.
15. Glasson, JR, Komeda M, Daughters GT, Foppiano LE, Bolger
AF, Tye TL, et al. Most ovine mitral annular 3-D size reduction
occurs before ventricular systole and is abolished with ventric-
ular pacing. Circulation 1997;96(Suppl II):II115-23.
16. Glasson JR, Komeda M, Daughters GT, Niczyporuk MA,
Bolger AF, Ingels NB, et al. Three-dimensional regional
dynamics of the normal mitral anulus during left ventricular
ejection. J Thorac Cardiovasc Surg 1996;111:574-85.
17. Schipke JD, Harasawa Y, Sugiura S, Alexander J, Burkhoff
D. Effect of a bradycardic agent on the isolated blood-
perfused canine heart. Cardiovasc Drugs Ther 1991;5:481-8.
18. Yun KL, Rayhill SC, Niczyporuk MA, Fann JI, Zipkin RE,
Derby GC, et al. Mitral valve replacement in dilated canine
hearts with chronic mitral regurgitation: importance of the
mitral subvalvular apparatus. Circulation 1991;84(Suppl):
112-24.
19. Moon MR, Castro LJ, Derby GC, Niczyporuk MA, Daugh-
ters GT, Ingels NB, et al. Calculation of biventricular volume:
myocardial marker vs. sonomicrometric shell subtraction
technique [abstract]. Circulation 1992;86(Suppl):I553.
20. Kono A, Maughan WL, Sunagawa K, Hamilton K, Sugawa K,
Weisfeldt ML. The use of left ventricular end-ejection pres-
sure and peak pressure in the estimation of the end-systolic
pressure-volume relationship. Circulation 1984;70:1057-65.
21. Gorman RC, McCaughan JS, Ratcliffe MB, Gupta KB,
Streicher JT, Ferrari VA, et al. Pathogenesis of acute isch-
emic mitral regurgitation in three dimensions. J Thorac
Cardiovasc Surg 1995;109:684-93.
22. Gorman JH, Gorman RC, Jackson BM, Hiramatsu Y,
Gikakis NS, Kelley ST, et al. Three-dimensional annular
changes in acute ischemic mitral regurgitation. Surg Forum
1996;47:288-91.
23. Sonnenblick EH, Napolitano LM, Daggett WM, Cooper T.
An intrinsic neuromuscular basis for mitral valve motion in
the dog. Circ Res 1967;21:9-15.
24. Angelini A, Ho SY, Anderson RH, Davies MJ, Becker A. A
histological study of the atrioventricular junction in hearts
with normal and prolapsed leaflets of the mitral valve. Br
Heart J 1988;59:712-6.
25. Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson
RH. Left ventricular fibre architecture in man. Br Heart J
1981;45:248-63.
26. Llaneras MR, Nance ML, Streicher JT, Linden PL, Downing
SW, Lima JA, et al. Pathogenesis of ischemic mitral insuffi-
ciency. J Thorac Cardiovasc Surg 1993;105:439-43.
27. Komeda M, Glasson JR, Bolger AF, Daughters GT, Mac-
Isaac A, Oesterle SN, et al. Geometric determinants of
ischemic mitral regurgitation. Circulation 1997;96(Suppl II):
II128-33.
28. Fucci C, Sandrelli L, Pardini A, Torracca L, Ferrari M,
Alfieri O. Improved results with mitral valve repair using new
surgical techniques. Eur J Cardiothorac Surg 1995;9:621-7.
29. Daughters GT, Sanders WJ, Miller DC, Schwarzkopf A,
Mead CW, Ingels NB. A comparison of two analytical
systems for three-dimensional reconstruction from biplane
videoradiograms. IEEE Comput Soc Press 1989;15:79-82.
30. Walmsley R. Anatomy of human mitral valve in adult cadaver
and comparative anatomy of the valve. Br Heart J 1978;40:
351-66.
Discussion
Dr. Steven F. Bolling (Ann Arbor, Mich.). As someone
who also uses this model on our laboratory, I know how
hard this information is to gather. We also have the
feeling in this ischemic syndrome that loitering (although
we did not use that word before today, but we will in the
future) was what the mitral leaflets were doing; they were
slow to get the idea of where they were supposed to go. I
have a number of questions for the authors. First, you
describe different degrees of MR occurring in the sheep,
ranging from mild in some to severe. Do you think there
are different mechanisms in mild versus severe MR in
these sheep or differing degrees of mechanisms for isch-
emic MR?
Second, the sheep anulus is anatomically not the same
as the human anulus. Are there differences that can be
seen in the human anulus?
Third, clinically most of us see chronic ischemic or
chronic MR associated with ischemia, not acute ischemia,
as this type of syndrome is described. What are the clinical
implications of this in terms of chronic ischemia that has
been ongoing for years and years?
Finally, in terms of clinical implications; all of these
concepts result in an increase in MA size perhaps and a
decrease in zone of coaptation. We agree that apical dis-
placement of the PMs and cords are not part of this
syndrome. But in terms of repairing these valves, recon-
structing these valves, is it not the bottom line to increase the
zone of coaptation and whether this occurs chronically or
whether it is important, if you increase the zone of coapta-
tion would that not take care of this syndrome in itself?
Dr. Glasson. Thank you for your comments, Dr.
Bolling. With regard to the degree of MR, the animals in
this experiment were all subjected to variable amounts of
ischemia, ranging between 2 and 7 minutes. We believe
that our observations pertain to the initial deformations in
the geometry of the mitral valve complex that occur at the
beginning of acute ischemia. The first deformation, then,
appears to be MA dilatation, with LV volume overload
probably ensuing subsequently. As such, the traditional
idea that MR begets more MR makes sense. The degree
of MR that we measured in these sheep may have varied
between animals based on the amount of ischemia that
each animal experienced. Also, it was difficult to deter-
mine the exact amount of MR present because the
quantification was based on echocardiographic analyses
and because the images obtained transthoracically are not
as accurate as what we can see and calculate with markers.
However, with regard to leaflet behavior, all animals with
leaflet edge markers behaved identically, that is, all ani-
mals showed leaflet loitering during acute ischemia, and
all animals had MR on echocardiography during this
ischemia. As such, I do not believe that there were
different mechanisms at work in different animals.
As far as the anatomy of the anulus, there are actually
many papers in the literature with conflicting data as to
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what type of fibers insert into the annular ring and where
these insertions occur. For example, one paper suggests
that sheep have a more muscular posterior anulus than do
human beings, but a recent study by Angelini and associ-
ates [see reference 24] showed that variability in left atrial
and LV muscle fiber insertions is present in the anuli of
human beings similarly as in dogs, sheep, and cows; they
could not pinpoint any obvious differences. The results of
these many anatomic studies may be conflicting because
of the diversity in the number of different individuals
studied in each case; that is, if one only looks at five
human anuli, the results are going to be quite different
than if one looks at 500 anuli.
With regard to clinical implications, yes, you are cor-
rect. This is a very acute study, and a long-term model
with chronic volume overload would likely produce differ-
ent results. As I have shown, these animals did not have
any increases in volume or long or short axis length of the
left ventricle during incomplete mitral leaflet coaptation
at end-diastole. As such, we believe that these annular
changes are acute and occur before the volume overload
that may distort ventricular geometry in the subacute or
chronic setting. Such subsequent distortion in ventricular
geometry may then in turn lead to more MR by various
different mechanisms, including LV dilatation and further
annular enlargement.
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